{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2877"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2877","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Is long-term survival higher in patients who receive propofol-based total intravenous anesthesia during colorectal cancer surgery compared to volatile anesthesia","abstract":"The study reviewed several retrospective cohort studies that examined the impact of propofol-based total intravenous anesthesia (TIVA) versus volatile anesthesia (VA) on the long-term survival of colorectal cancer (CRC) surgery patients. Eight studies found no significant difference in mortality between the two anesthesia types, while three studies indicated a significant decrease in all-cause mortality favoring propofol TIVA. The studies had varying follow-up periods, with some extending to five years. Notably, two studies controlled the type of volatile anesthetic used, specifically sevoflurane and desflurane. The findings suggest a potential survival advantage for propofol TIVA, warranting further investigation.","abstract_html":"The study reviewed several retrospective cohort studies that examined the impact of propofol-based total intravenous anesthesia (TIVA) versus volatile anesthesia (VA) on the long-term survival of colorectal cancer (CRC) surgery patients. Eight studies found no significant difference in mortality between the two anesthesia types, while three studies indicated a significant decrease in all-cause mortality favoring propofol TIVA. The studies had varying follow-up periods, with some extending to five years. Notably, two studies controlled the type of volatile anesthetic used, specifically sevoflurane and desflurane. The findings suggest a potential survival advantage for propofol TIVA, warranting further investigation.","abstract_has_math":false,"creators":["Mitchell, Shad Anthony"],"institution":null,"degree_name":"Management Practice in Nurse Anesthesia","degree_level":"Research Paper","degree_discipline":"College of Business","degree_department":null,"school":null,"contributors":["Alberto Coustasse, Dr.PH. MD, MBA, MPH","Cassandra L. Taylor, DNP, DMP, APRN, CRNA"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:10Z","subjects":["Anesthesiology","Business","Business Administration, Management, and Operations","Health and Medical Administration","Medical Specialties","Medicine and Health Sciences","Nursing","Oncology","colorectal cancer","total intravenous anesthesia","volatile anesthesia","inflammation"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1872","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1872","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2877","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Alberto Coustasse, Dr.PH. MD, MBA, MPH","Cassandra L. Taylor, DNP, DMP, APRN, CRNA"]},{"key":"dc:creator","label":"Author","values":["Mitchell, Shad Anthony"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-08-23T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["College of Business"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Research Paper"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Management Practice in Nurse Anesthesia"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Anesthesiology","Business","Business Administration, Management, and Operations","Health and Medical Administration","Medical Specialties","Medicine and Health Sciences","Nursing","Oncology","colorectal cancer","total intravenous anesthesia","volatile anesthesia","inflammation"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1872"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The study reviewed several retrospective cohort studies that examined the impact of propofol-based total intravenous anesthesia (TIVA) versus volatile anesthesia (VA) on the long-term survival of colorectal cancer (CRC) surgery patients. Eight studies found no significant difference in mortality between the two anesthesia types, while three studies indicated a significant decrease in all-cause mortality favoring propofol TIVA. The studies had varying follow-up periods, with some extending to five years. Notably, two studies controlled the type of volatile anesthetic used, specifically sevoflurane and desflurane. The findings suggest a potential survival advantage for propofol TIVA, warranting further investigation."]},{"key":"dc:title","label":"Title","values":["Is long-term survival higher in patients who receive propofol-based total intravenous anesthesia during colorectal cancer surgery compared to volatile anesthesia"]}]}],"canonical_facts":{"dc:contributor":["Alberto Coustasse, Dr.PH. MD, MBA, MPH","Cassandra L. Taylor, DNP, DMP, APRN, CRNA"],"dc:creator":["Mitchell, Shad Anthony"],"dc:date.available":["2024-08-23T07:00:00Z"],"dc:date.created":["2024-01-01T08:00:00Z"],"dc:description.abstract":["The study reviewed several retrospective cohort studies that examined the impact of propofol-based total intravenous anesthesia (TIVA) versus volatile anesthesia (VA) on the long-term survival of colorectal cancer (CRC) surgery patients. Eight studies found no significant difference in mortality between the two anesthesia types, while three studies indicated a significant decrease in all-cause mortality favoring propofol TIVA. The studies had varying follow-up periods, with some extending to five years. Notably, two studies controlled the type of volatile anesthetic used, specifically sevoflurane and desflurane. The findings suggest a potential survival advantage for propofol TIVA, warranting further investigation."],"dc:identifier":["https://mds.marshall.edu/etd/1872"],"dc:subject":["Anesthesiology","Business","Business Administration, Management, and Operations","Health and Medical Administration","Medical Specialties","Medicine and Health Sciences","Nursing","Oncology","colorectal cancer","total intravenous anesthesia","volatile anesthesia","inflammation"],"dc:title":["Is long-term survival higher in patients who receive propofol-based total intravenous anesthesia during colorectal cancer surgery compared to volatile anesthesia"],"thesis:degree_discipline":["College of Business"],"thesis:degree_level":["Research Paper"],"thesis:degree_name":["Management Practice in Nurse Anesthesia"]},"updated_at":"2026-11-21T19:58:10Z"}